XDDX:XETRA:XETRA-Xtrackers DAX ESG Screened UCITS ETF 1D (EUR)

ETF | Others |

Last Closing

USD 129.46

Change

-0.88 (-0.68)%

Market Cap

USD 0.29B

Volume

3.00K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.41 (+0.79%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.13 (+0.77%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.26 (+0.97%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.21 (+0.73%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.10 (+0.41%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+0.02 (+0.01%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

+0.01 (+0.01%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.40 (+0.78%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.19 (+0.20%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+1.48 (+0.27%)

USD 80.38B

ETFs Containing XDDX:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.51% 59% D- 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.51% 58% F 60% D-
Trailing 12 Months  
Capital Gain 23.04% 67% D+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.04% 67% D+ 67% D+
Trailing 5 Years  
Capital Gain 30.77% 47% F 51% F
Dividend Return 8.41% 77% C+ 47% F
Total Return 39.18% 53% F 55% F
Average Annual (5 Year Horizon)  
Capital Gain 5.73% N/A N/A 52% F
Dividend Return 7.59% N/A N/A 58% F
Total Return 1.87% N/A N/A 67% D+
Risk Return Profile  
Volatility (Standard Deviation) 15.64% N/A N/A 44% F
Risk Adjusted Return 48.53% N/A N/A 56% F
Market Capitalization 0.29B 53% F 47% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike